PAK2通过酸化E-cadherin促进CTC集群的形成,以增强乳腺癌中的细胞-细胞粘附
Lihuang Guo1,2, Jiancheng Li1,2, Wenxing Zhu1,2
1Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, China.
Breast cancer research : BCR
|December 21, 2025
概括
通过增强E-cadherin粘附,促进循环瘤细胞 (CTC) 集群形成,从而驱动乳腺癌转移的p21激活激酶2 (PAK2). 用FRAX597准PAK2可以抑制瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 循环瘤细胞 (CTC) 集群具有比单个CTC更大的转移潜力,与较差的癌症存活率相关.
- 构成CTC集群的分子机制尚不清楚.
- 21激活激酶2 (PAK2) 参与细胞骨重塑,并与晚期瘤进展有关.
研究的目的:
- 调查PAK2在乳腺癌中CTC集群的形成中的作用.
- 阐明PAK2影响CTC集群形成和转移的分子机制.
主要方法:
- 来自单个CTC和CTC集群的转录组数据的综合生物信息学分析.
- 使用 in vitro 细胞模型和 in vivo ортотоп 鼠标模型进行功能验证.
- 关于PAK2介导的E-cadherin酸化和PAK抑制剂的治疗评价的机制研究.
主要成果:
- CTC集群表现出增强的细胞-细胞粘附,增殖和生存.
- 乳腺癌中PAK2的升高调节,与预后不佳有关.
- PAK2通过酸化E-cadherin促进CTC集群的形成,增强细胞粘附;通过FRAX597抑制减少瘤生长和转移.
结论:
- 通过通过CTC集群形成增强E-cadherin介导的细胞-细胞粘附,PAK2促进乳腺癌转移.
- PAK2代表了潜在的治疗标和诊断标记,用于预防乳腺癌转移.
相关概念视频
Cadherins in Tissue Organization
3.8K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.8K
Structure of Cadherins
4.6K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins” is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
4.6K
Catenins
3.0K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.0K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


